Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Sinergi Multi Lestarindo Tbk. (SMLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Sinergi Multi Lestarindo Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 45.1K 24h volume), while Sinergi Multi Lestarindo Tbk. trades at Rp167 (market cap 412.08B, 13.91M 24h volume). The key difference: Sinergi Multi Lestarindo Tbk. is far larger — about 2.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Sinergi Multi Lestarindo Tbk. is more actively traded (13.91M versus 45.1K). Which is the better fit depends on your goals.
| OBAT | SMLE | |
|---|---|---|
Market Cap | 164.65B | 412.08B |
Volume | 45.1K | 13.91M |
Lot | 451 | 139.1K |
Turnover | 10.89M | 2.4B |
Average Price | 241.39 | 172.48 |
Value | 10.89M | 2.4B |
Indicative Equilibrium Price | 238 | 174 |
Indicative Equilibrium Volume | 100 | 1.06K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Sinergi Multi Lestarindo Tbk.
PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Read more on SMLE →
